Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Neurology · Neurology · 2026-11-10
Meta-analysisn = 14,516
Ingwersen et al. Severity-Based Triage for Direct Transportation to Nearest Comprehensive Stroke Center: A Systematic Review and Meta-AnalysisNeurology · JAMA · 2026-11-10
RCTn = 998
Li et al. Loberamisal for Acute Ischemic Stroke: The LAIS Randomized Clinical TrialNeurology · Lancet Neurol · 2026-11-01
RCTn = 26
Veerapandiyan et al. Safety and efficacy of delpacibart zotadirsen in Duchenne muscular dystrophy mutations amenable to exon 44 skipping in the USA (EXPLORE44): a randomised, placebo-controlled, double-blind, phase 1/2 trialNeurology · JAMA Neurol · 2026-11-01
RCTn = 220
Estragués-Gázquez et al. Earlier Disclosure of Blood-Based Biomarkers, Diagnostic Certainty, and Clinical Management: A Randomized Clinical TrialNeurology · JAMA Neurol · 2026-11-01
RCTn = 1,656
Hauser et al. Ten Years of Ocrelizumab in Relapsing Multiple Sclerosis: The OPERA I and II Randomized Clinical TrialsNeurology · JAMA Neurol · 2026-11-01
RCTn = 703
Chen et al. Hearing Intervention for Older Adults With Mild Cognitive Impairment: The CHOICE Randomized Clinical TrialNeurology · JAMA Neurol · 2026-11-01
RCTn = 44
Özkaynar et al. Intravenous Immunoglobulin Add-On in Newly Diagnosed Idiopathic Inflammatory Myopathies: A Randomized Clinical TrialNeurology · Neurology · 2026-10-22
Secondary analysisn = 247
Anderson et al. Antidopaminergic Medications and Clinical Outcomes in Huntington Disease: Evidence From the PROOF-HD Placebo-Controlled TrialNeurology · Neurology · 2026-10-08
RCTn = 11,288
Ren et al. Effects of Blood Pressure Lowering by Hematoma Location in Acute Intracerebral HemorrhageNeurology · Lancet Neurol · 2026-10-01
RCTn = 305
Cudkowicz et al. Safety, tolerability, and efficacy of RIPK1 inhibitor, SAR443820, in amyotrophic lateral sclerosis (HIMALAYA): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialNeurology · JAMA Neurol · 2026-10-01
RCTn = 970
Wang et al. Tirofiban for Branch Atheromatous Disease-Related Stroke: The STRATEGY Randomized Clinical TrialNeurology · Neurology · 2026-09-16
Meta-analysisn = 14,239
Katsanos et al. Factor XIa Inhibitors for Secondary Prevention After Noncardioembolic Stroke: A Systematic Review and Meta-AnalysisNeurology · Ann Neurol · 2026-09-08
Secondary analysisn = 434
Tanaka et al. Non-contrast CT Markers of Hematoma Expansion and Andexanet Response in Factor Xa Inhibitor-Associated Intracerebral Hemorrhage: An Analysis from ANNEXa-I TrialNeurology · Lancet Neurol · 2026-09-01
Meta-analysisn = 316,131
Dremel et al. Prevalence of unruptured intracranial aneurysms according to comorbidities, risk factors, country, and time period: a systematic review and meta-analysisNeurology · Neurology · 2026-09-01
Meta-analysisn = 4,786
Liampas et al. Prevalence of Slowly Expanding Lesions in Patients With Multiple Sclerosis: A Systematic Review and Meta-AnalysisNeurology · Neurology · 2026-08-31
Guideline
Potrebic et al. Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache SocietyNeurology · Lancet Neurol · 2026-08-24
RCTn = 92
Plazzi et al. Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trialNeurology · BMJ · 2026-08-20
RCTn = 1,368
Yuan et al. Head positioning after endovascular therapy for acute stroke due to large vessel occlusion (HeadSOAR): multicentre randomised controlled trialNeurology · Neurology · 2026-08-20
Secondary analysisn = 550
Huang et al. Effect of Baseline ASPECTS on Tenecteplase Efficacy Before Thrombectomy in Acute Large-Vessel Occlusion Stroke: A Post Hoc Analysis of the BRIDGE-TNK Randomized Trial